Last reviewed · How we verify
NCT07511777
Clinical Trial to Assess the Safety and Efficacy of Intra-articular Injection Collagen Versus Hyaluronic Acid on Knee Osteoarthritis
NA trial testing CartiZol in Osteoarthitis in 100 participants. Completed in 13 November 2025.
5 August 2025
Quick facts
| Lead sponsor | Cellontech Co., Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 6 February 2024 |
| Primary completion | 5 August 2025 |
| Estimated completion | 13 November 2025 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- CartiZol
- Synovian inj.
Conditions studied
- Osteoarthitis — all drugs for Osteoarthitis →
Sponsor
Cellontech Co., Ltd. — full company profile →
Who can join
19 and older, any sex, with Osteoarthitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was designed to assess the efficacy for pain relief, functional improvement, and safety of intra-articular collagen injections compared to hyaluronic acid injections for knee osteoarthritis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07511777
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Osteoarthitis
Currently open trials in the same condition.
- NCT07361198 — Percutaneous Transcatheter Genicular Embolization in Osteoarthritis · NA · recruiting
- NCT07391592 — Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate · active not recruiting
- NCT07474571 — Evaluation of Musculoskeletal Aging and Related Disorders Via Advanced Clinical Imaging · recruiting
Other Cellontech Co., Ltd. trials
Trials by the same sponsor.
- NCT02519881 — the Efficacy and Safety of a Modified Microfracture Using Collagen Compared to Those of a Simple Microfracture in Ankle · NA · completed
- NCT02539082 — the Safety and Efficacy of Collagen Injection in Patients With Plantar Fasciitis · NA · completed
- NCT02539069 — The Post-marketing Surveillance to Evaluate the Efficacy of CHONDRON (Autologous Cultured Chondrocyte) by Arthroscopy · NA · completed
- NCT02539056 — The Post-marketing Surveillance to Evaluate the Efficacy and Safety of a CHONDRON (Autologous Cultured Chondrocyte) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07511777 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cellontech Co., Ltd.
- Last refreshed: 13 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07511777.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing